![Clare Ozawa](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clare Ozawa
Directeur/Membre du Conseil chez
Inception IBD, Inc.
Profil
Clare R.
Ozawa is currently Director at Inception Sciences, Inc. since 2017, Director at Inception IBD, Inc., 858 Therapeutics, Inc., Jengu Therapeutics, Inc., Capsida Biotherapeutics, Inc., Stablix, Inc., and Kate Therapeutics, Inc., and Managing Director at Versant Venture Management LLC since 2017.
Former roles include Chief Executive Officer at McKinsey & Co., Inc. in 2006, Chief Executive Officer at Novartis Pharma AG from 2006 to 2008, Independent Director at Oyster Point Pharma, Inc. from 2019 to 2023, Director at Contineum Therapeutics, Inc., and Investment Professional at Versant Venture Management LLC from 2008 to 2010.
Education includes undergraduate studies at Stanford University and a doctorate from Stanford University School of Medicine conferred in 2002.
Postes actifs de Clare Ozawa
| Sociétés | Poste | Début |
|---|---|---|
Inception IBD, Inc.
 Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Directeur/Membre du Conseil | - |
Inception Sciences, Inc.
 Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Directeur/Membre du Conseil | 01/06/2014 |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage drug discovery and biotechnology company that develops molecule drugs for novel therapeutics targets in oncology & immunology | Directeur/Membre du Conseil | - |
Jengu Therapeutics, Inc.
 Jengu Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Directeur/Membre du Conseil | - |
Capsida Biotherapeutics, Inc.
 Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Directeur/Membre du Conseil | - |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Directeur/Membre du Conseil | - |
Kate Therapeutics, Inc.
 Kate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops adeno-associated virus based gene therapies | Directeur/Membre du Conseil | - |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Private Equity Investor | 01/01/2017 |
Anciens postes connus de Clare Ozawa
| Sociétés | Poste | Fin |
|---|---|---|
| OYSR POIN | Directeur/Membre du Conseil | 03/01/2023 |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Clare Ozawa
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
85
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Ventures invests in biotechnology companies located globally. The firm participates in early and later stage capital requirements. | Finance |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Stanford University School of Medicine
 Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inception Sciences, Inc.
Inception Sciences, Inc. Pharmaceuticals: MajorHealth Technology Provides small molecule pharmaceutical incubator services | Health Technology |
Inception IBD, Inc.
Inception IBD, Inc. Miscellaneous Commercial ServicesCommercial Services Provides therapeutics services | Commercial Services |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Commercial Services |
Pipeline Therapeutics, Inc.
 Pipeline Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops novel, oral small molecule therapies for neuroscience, inflammation and immunology indications | Health Technology |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage drug discovery and biotechnology company that develops molecule drugs for novel therapeutics targets in oncology & immunology | Health Technology |
Jengu Therapeutics, Inc.
Jengu Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in the development of gene therapies for life threatening genetic disorders | Health Technology |
Stablix, Inc.
Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical stage biotechnology company, which pioneering small molecule medicines for targeted protein stabilization | Commercial Services |
Kate Therapeutics, Inc.
Kate Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops adeno-associated virus based gene therapies | Health Technology |
